CHENGDA PHARMACEUTICALS CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.13 CNY | +1.43% |
|
+1.97% | -24.77% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Chengda Pharmaceuticals Co Ltd is a China-based company mainly engaged in customized R&D and production of pharmaceutical intermediates. The Company is also engaged in the production and sales of L-carnitine series products and active pharmaceutical ingredients (APIs). The pharmaceutical intermediate products include NP0805/NP0908, NP1205, NP0806, NP1011/1214, NP1709 and others. The L-carnitine series products are used in the fields of food additives, feed additives and raw materials. The APIs products include Buwaxitan, Vidagliptin, Elagoli and others. The Company's products are exported to the United States, Europe, Japan, Canada, the United Kingdom, Italy and other countries and regions.
Sector
Pharmaceuticals
Calendar
2024-05-13
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -24.77% | 403M | |
| +24.17% | 562B | |
| -6.55% | 358B | |
| +19.27% | 322B | |
| +8.01% | 297B | |
| +13.45% | 219B | |
| +6.04% | 199B | |
| -10.51% | 196B | |
| -11.65% | 149B | |
| -6.83% | 146B |
- Stock Market
- Equities
- 301201 Stock
- News ChengDa Pharmaceuticals Co., Ltd.
- ChengDa Pharmaceuticals to Free Up 1.29% Stake For Trading
